Counterfeit medicines and the GPHF-minilab for rapid drug quality verification

Pharmazeutische Industrie

Volumn 66, Issue 10, 2004, Pages 1187-1193

  Jähnke, Richard W O ^a,b  

^a German Pharma Hlth Fund eV (GPHF)   (Germany)

^b Ger Pharma Health Fund eV (GPHF)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ARTICLE; CHILDHOOD DISEASE; DRUG INDUSTRY; DRUG QUALITY; FORGERY; GERMANY; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL; LABORATORY DIAGNOSIS; QUALITY CONTROL; RELIABILITY;

EID: 8644257553     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Geiling, E. M. K., Cannon, P. R., Pathologic effects of sulphanilamide (diethylene glycol) poisoning: a clinical and experimental correlation, final report, J. Am. Med. Assoc. 111, 919 (1938)
2. Wax, D. M., Elixirs, diluents and the passage of the 1938 Federal Food, Drug and Cosmetics Act, Ann. Intern. Med. 5, 456 (1995)
3. Hanif, M., Mobarak, M. R., Ronan, A. et al., Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic, Brit. Med. J. 311, 88 (1995)
4. Silverman, M., Lydecker, M., Lee, P. R., The Drug Swindlers, Int. J. Health Serv. 20, 561 (1990)
5. Pierce, G., Glycerol contaminated with diethylene glycol, WHO Drug Information 12, 129 (1998)
6. WHO, Information Exchange Service Alert 13, 1 (1990)
7. McGregor, A., Counterfeit drugs flood developing world, Lancet 350, 1690 (1997)
8. Csillag, C., Epidemic of counterfeit drugs causes concern in Brazil, Lancet 352, 553 (1989)
9. Wondemagegnehu, E., Counterfeit and substandard drugs in Myanmar and Vietnam, EDM Research Series, No. 29, WHO/EDM/QSM/99.3, WHO, Geneva (1999)
10. Law, J., Challenging the counterfeiters, Scrip Magazine, February 1999, pp. 28-32
11. Italian police seize counterfeit medicines (Editorial), Scrip World Pharmaceutical News, No. 2557 (2000)
12. Chakravarty, S., Deadly doses, India Today, January 29, 2001, pp. 58-61
13. Wicaksono, Wiyana, D., Kuswardono, A. A., Get sick quick: the dangers of counterfeit drugs, Tempo Indonesia, September 3, pp. 41-49 (2001)
14. Shakoor, O., Taylor, R. B., Behrens, R. H., Assessment of the incidence of sub-standard drugs in developing countries, Trop. Med. Int. Health 2, 839 (1997)
15. Counterfeit drugs a health threat in US (Editorial), Scrip World Pharmaceutical News, No. 2662 (2001)
16. Goodman, P. S., China's Killer Headache: Fake Pharmaceuticals, The Washington Post, August 30 (2002)
17. Hildebrand, J. R., Arzneimittelfälschungen in den USA, Pharm. Ind. 64, 147 (2002)
18. TenHam, M., Counterfeit drugs: implications for health, Adverse Drug React. Toxicol. Rev. 11, 59 (1992)
19. Sesay, M., Fake drugs - a new threat of health care delivery, Africa Health, June 1988, pp. 13-15
20. Newton, P. N., White, N. J., Rozendaal, J. A. et al., Murder by fake drugs - Time for international action, Brit. Med. J. 324, 800 (2002)
21. WHO Fact Sheet, No. 275, WHO, Geneva, November 2003
22. WHO Department of Essential Drugs and Other Medicines, Guidelines for the development of measures to combat counterfeit drugs WHO/EDM/ QSM/99.1, WHO, Geneva (1999)
23. WHO counterfeit action plan (Editorial), Scrip World Pharmaceutical News, No. 2904 (2003)
24. State DCA setting up modern drug testing lab to be operational by 2004 (Editorial), Pharma Biz, Hyderabad (India), August 20 (2003)
25. Newton, P. N., Proux, S., Green, M. et al., Fake artesunate in southeast Asia, Lancet 357, 1948 (2001)
26. Lea, F. N., Traitement antisida: Un faut gènérique sur le marché, Nouvelles Expressions, Cameroon, February 21 (2003)
27. Rozendaal, J., Fake antimalaria drugs in Cambodia, Lancet 375, 890 (2001)
28. Basco, L. K., Ringwald, P., Manéné, A. B. et al., False chloroquine resistance in Africa, Lancet 350, 224 (1997)
29. Clark, C., Counterfeiting abroad and at home, Pharm. J. 271, 453 (2003)
30. Crackdown on illegal sale of medicines in Benin, WHO Essential Drugs Monitor 27, 5 (1999)
31. Malaria: Dozens dead in Cambodia from counterfeit drugs, United Nations Foundation UN Wire, May 30 (2000)
32. Jähnke, R. W. O., Küsters, G., Fleischer, K., Low-cost quality assurance of medicines using the GPHF-Minilab, Drug Inf. J. 35, 941 (2001)
33. Jähnke, R. W. O., Kallmayer, H.-J., Breyer, C. et al., Concise Quality Control Guide On Essential Drugs, Vol. I, Colour Reactions, German Pharma Health Fund, Frankfurt (1998); Supplements 1999 and 2002
34. Jähnke, R. W. O., Pachaly, P., Gobina, N. P. et al., Concise Quality Control Guide On Essential Drugs, Vol. II, Thin Layer Chromatography, German Pharma Health Fund, Frankfurt (1998); Supplements 1999, 2002, 2003 and 2004
35. Capell, K., Timmons, S., Wheatley, J. et al., What's in that pill? In Latin America, fake drugs are as lucrative as cocaine, Business Week, June 18, pp. 26-27 (2001)
36. Maponga, C., Ondari, C., The quality of antimalarials - A study in selected African countries, Report WHO/ EDM/PAR/2003.4, WHO, Geneva (2003)
37. Basco, L. K., Molecular epidemiology of malaria in Cameroon, XIC. Quality of antimalarial drugs used for self-medication, Am. J. Trop. Med. Hyg. 70, 245 (2004)
38. Vachon, M., Test shows 1 in 4 malaria drugs sold in provinces is fake, The Cambodia Daily, August 28, p 20 (2003)
39. Phanouvong, S., Mid-Project Review Meeting on the USP/WHO Mekong Antimalarial Drug Quality Monitoring Project, Vientiane, Laos PDR, July 7-9 (2004) sxp@usp.org
40. Kron, M. A., Substandard primaquine phosphate for US Peace Corps personnel, Lancet 348, 1453 (1996)